Adalimumab starter pack 40 MG/0.8 ML Pen (6 count)

What was the prescribed dosage? 1-5mg 6-10mg 11-50mg 51-100mg 101-200mg 201-500mg 501mg-1g

Here is the some steps to help you to save money on Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) purchase.

• Read drug prescription
• What is adalimumab starter pack 40 MG/0.8 ML Pen (6 count)
• Important safety information:
• Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) side effects
• Select the most affordable brand or generic drug
• Frequently asked Questions
• How should I take adalimumab starter pack 40 MG/0.8 ML Pen (6 count)?
• Who should not take adalimumab starter pack 40 MG/0.8 ML Pen (6 count)?
• Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) reviews

Read drug prescription

What is adalimumab starter pack 40 MG/0.8 ML Pen (6 count)

Treating a variety of moderate to severe inflammatory conditions (eg, rheumatoid arthritis, juvenile idiopathic arthritis [JIA], psoriatic arthritis, ankylosing spondylitis). It is also used to treat certain patients with moderate to severe Crohn disease, ulcerative colitis, or chronic plaque psoriasis. It may be used alone or in combination with other medicine. It may also be used for other conditions as determined by your doctor.
Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) is a TNF blocker. It works by blocking a protein (TNF-alpha) found in the body that causes inflammation.

Important safety information:

• adalimumab starter pack 40 MG/0.8 ML Pen may cause dizziness or vision changes. These effects may be worse if you take it with alcohol or certain medicines. Use adalimumab starter pack 40 MG/0.8 ML Pen (6 count) with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.
• Do NOT use more than the recommended dose or use for longer than prescribed without checking with your doctor.
• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.
• Before you use adalimumab starter pack 40 MG/0.8 ML Pen (6 count), discuss your vaccination history with your doctor to be sure that you are up to date on vaccines.
• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) may increase the risk of developing blood cancer (eg, leukemia, lymphoma) or other types of cancer. This may be fatal in some cases. Discuss any questions or concerns with your doctor. Tell your doctor if you have ever had cancer. Contact your doctor right away if you develop any unusual symptoms, such as unusual bruising, unusual lumps or swelling (eg, in your neck, armpit, or groin), night sweats, recurring fever, unusual tiredness or weakness, unexplained cough or shortness of breath, persistent unexplained itching, or unexplained weight loss.
• New or worsening nervous system problems (eg, MS, optic neuritis, Guillain-Barré syndrome) have occurred with TNF blockers. Tell your doctor if you have a condition that affects your nervous system. Discuss any questions or concerns with your doctor.
• Some patients who use adalimumab starter pack 40 MG/0.8 ML Pen (6 count) have developed new or worsening psoriasis. Tell your doctor right away if you notice any new or worsening skin problems (eg, red, flaky, or itchy skin patches).
• Severe liver problems have occurred with TNF blockers. Contact your doctor right away if you develop symptoms of liver problems (eg, dark urine; loss of appetite; pale stools, unusual stomach pain, tiredness, or vomiting; yellowing of the skin or eyes).
• Tell your doctor or dentist that you take adalimumab starter pack 40 MG/0.8 ML Pen (6 count) before you receive any medical or dental care, emergency care, or surgery.
• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) may reduce the number of clot-forming cells (platelets) in your blood. Avoid activities that may cause bruising or injury. Tell your doctor if you have unusual bruising or bleeding. Tell your doctor if you have dark, tarry, or bloody stools.
• Do not receive a live vaccine (eg, measles, mumps) or treatment with a weakened bacteria (eg, BCG for bladder cancer) while you are taking adalimumab starter pack 40 MG/0.8 ML Pen (6 count). Talk with your doctor before you receive any vaccine.
• If you used adalimumab starter pack 40 MG/0.8 ML Pen (6 count) while you were pregnant, tell your baby's doctor.
• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) may interfere with certain lab tests, including tests for TB infection. Be sure your doctor and lab personnel know you are using adalimumab starter pack 40 MG/0.8 ML Pen (6 count).
• Lab tests, including TB, liver function, and complete blood cell counts, may be performed while you use adalimumab starter pack 40 MG/0.8 ML Pen (6 count). These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.
• Use adalimumab starter pack 40 MG/0.8 ML Pen (6 count) with caution in the ELDERLY; they may be more sensitive to its effects, especially an increased risk of infection and certain types of cancer.
• Caution is advised when using adalimumab starter pack 40 MG/0.8 ML Pen (6 count) in CHILDREN; they may be at increased risk of developing certain types of cancer with adalimumab starter pack 40 MG/0.8 ML Pen (6 count), which may be fatal.
• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using adalimumab starter pack 40 MG/0.8 ML Pen (6 count) while you are pregnant. It is not known if adalimumab starter pack 40 MG/0.8 ML Pen (6 count) is found in breast milk. Do not breast-feed while using adalimumab starter pack 40 MG/0.8 ML Pen (6 count).

Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) side effects

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back pain; headache; mild pain, redness, or swelling at the injection site; mild stomach pain; nausea; runny or stuff nose.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); black, tarry, or bloody stools; blood in the urine; burning, numbness, or tingling; butterfly-shaped rash on the nose and cheeks; change in the appearance of a mole; chest pain; confusion; fainting; fast or irregular heartbeat; mental or mood changes; muscle aches, pain, or weakness; new or worsening joint pain; new or worsening red, scaly patches or raised bumps filled with pus on the skin; open sore that does not heal; persistent pain, swelling, or redness at the injection site; red, swollen, blistered, or peeling skin; severe or persistent headache or dizziness; severe or persistent stomach pain; shortness of breath; signs of infection (eg, fever, chills, or persistent sore throat; persistent cough; blood in the phlegm; flu-like symptoms; warm, red, or painful skin or sores; diarrhea; increased or painful urination); swelling of the ankles, hands, or feet; tremor; unexplained weight loss or weight gain; unusual bruising or bleeding; unusual lumps; unusual skin growth or other skin changes; unusual tiredness or weakness; unusually pale skin; vision changes; vomit that looks like coffee grounds.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Active ingredients: Adalimumab

Select the most affordable brand or generic drug

Strength	Quantity	Price, USD	Country
0.1 ML Humira 100 MG/ML Prefilled Syringe
0.1 ML adalimumab 100 MG/ML Prefilled Syringe
0.2 ML Humira 50 MG/ML Prefilled Syringe
0.2 ML adalimumab 100 MG/ML Prefilled Syringe
0.2 ML adalimumab 50 MG/ML Prefilled Syringe
0.4 ML Humira 100 MG/ML Pen Injector
0.4 ML adalimumab 100 MG/ML Pen Injector
0.4 ML adalimumab 100 MG/ML Prefilled Syringe
0.4 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]
0.8 ML Humira 100 MG/ML Pen Injector
0.8 ML Humira 50 MG/ML Injection
0.8 ML adalimumab 100 MG/ML Pen Injector [Humira]
0.8 ML adalimumab 50 MG/ML Injection
0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]
Adalimumab
Humira 10 MG per 0.1 ML Prefilled Syringe
Humira 10 MG per 0.2 ML Prefilled Syringe
Humira 40 MG in 0.4 ML Auto-Injector
Humira 40 MG in 0.4 ML Prefilled Syringe
Humira 40 MG in 0.8 ML Prefilled Syringe
Humira 40 MG per 0.4 ML Pen Injector
Humira 40 MG per 0.8 ML Prefilled Syringe
Humira 80 MG in 0.8 ML Prefilled Syringe
Humira Pediatric Crohn's Disease Starter Package (2 count)
Humira Pediatric Crohn's Disease Starter Package (6 count)
Humira Pen 80 MG/0.8 ML - Starter Package for Crohn's Disease, Ulcerative Colitis or Hidradenitis Suppurativa (3 count)
Humira Pen Crohn's Disease Starter Package
Humira Psoriasis Starter Pack 40 MG/0.8 ML Pen (4 count)
Humira Pédiatrique
Pediatric Crohn's Disease Starter Package (3 count)
adalimumab 20 MG in 0.2 ML Prefilled Syringe
adalimumab 20 MG in 0.4 ML Prefilled Syringe
adalimumab 40 MG in 0.4 ML Pen Injector
adalimumab 40 MG in 0.8 ML Auto-Injector
adalimumab 40 MG per 0.4 ML Prefilled Syringe
adalimumab 40 MG per 0.8 ML Auto-Injector
adalimumab 80 MG per 0.8 ML Pen Injector
adalimumab pediatric starter pack 40 MG/0.8 ML Prefilled Syringe (6 count)
adalimumab starter pack 40 MG/0.4 ML Pen (4 count)
isopropyl alcohol 70 % Topical Swab
{1 (0.4 ML adalimumab 100 MG/ML Prefilled Syringe [Humira]) / 1 (0.8 ML adalimumab 100 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (2 count)]
{3 (0.8 ML adalimumab 100 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Prefilled Syringe 80 MG/0.8 ML Starter Pack - Pediatric Crohn's Disease]
{4 (0.4 ML adalimumab 100 MG/ML Auto-Injector) } Pack
{6 (0.8 ML adalimumab 50 MG/ML Auto-Injector) } Pack

References

1. Dailymed."Humira (adalimumab) kit humira (adalimumab) injection, solution [abbvie inc.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
2. "Adalimumab". https://pubchem.ncbi.nlm.nih.gov/su... (accessed August 28, 2018).
3. "Adalimumab - drugbank". http://www.drugbank.ca/drugs/DB0005... (accessed August 28, 2018).

Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) - Frequently asked Questions

Can Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

How should I take adalimumab starter pack 40 MG/0.8 ML Pen (6 count)?

Use adalimumab starter pack 40 MG/0.8 ML Pen (6 count) as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get adalimumab starter pack 40 MG/0.8 ML Pen (6 count) refilled.
• adalimumab starter pack 40 MG/0.8 ML Pen (6 count) is given as an injection under the skin. A health care provider will teach you how to use it. adalimumab starter pack 40 MG/0.8 ML Pen (6 count) also comes with detailed instructions for use. Read them carefully. Be sure you understand how to use adalimumab starter pack 40 MG/0.8 ML Pen (6 count). Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.
• Do not use adalimumab starter pack 40 MG/0.8 ML Pen (6 count) if it contains particles, is cloudy or discolored, or if the syringe or pen is cracked or damaged.
• Use the proper technique taught to you by your doctor. Inject deep under the skin, NOT into muscle.
• Rotate injection sites. New injections should be given at least 1 inch from an old site. Do not inject into areas where the skin is tender, bruised, red, or hard, or where you have scars or stretch marks.
• Keep this product, as well as syringes and needles, out of the reach of children and away from pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.
• If you miss a dose of adalimumab starter pack 40 MG/0.8 ML Pen (6 count), use it as soon as you remember. Then go back to your regular dosing schedule. If you are not sure when to use adalimumab starter pack 40 MG/0.8 ML Pen (6 count), check with your doctor or pharmacist.

Ask your health care provider any questions you may have about how to use adalimumab starter pack 40 MG/0.8 ML Pen (6 count).

Who should not take adalimumab starter pack 40 MG/0.8 ML Pen (6 count)?

Some medical conditions may interact with adalimumab starter pack 40 MG/0.8 ML Pen (6 count). Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding
• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement
• if you have allergies to medicines, foods, or other substances, including rubber or latex
• if you have a history of an infection that keeps coming back, TB infection, or positive TB skin test
• if you have a history of hepatitis B infection or other liver problems; heart problems (eg, heart failure); high cholesterol; high blood pressure; diabetes; cancer (eg, lymphoma); blood problems; bone marrow problems; an autoimmune disorder (eg, lupus); other immune system problems (eg, weakened immune system); or numbness, tingling, or other nervous system problems (eg, multiple sclerosis [MS], optic neuritis, Guillain-Barré syndrome)
• if you have recently received a vaccine, are scheduled to receive a vaccine, or are scheduled to have surgery
• if you have an infection, open cuts or sores on your body, flu-like symptoms or other signs of infection (eg, fever; sweats; chills; cough; warm, red, or painful skin), or are using medicine to treat an infection
• if you have ever lived in or traveled to an area where TB is common, or if you have come into close contact with a person with active TB
• if you live or have lived in certain parts of the country (eg, Ohio or Mississippi river valleys) where certain types of fungal infections (eg, histoplasmosis, coccidioidomycosis, blastomycosis) are common. Check with your doctor if you are not sure if you have lived in an area where these infections are common
• if you have recently received treatment with rituximab or another TNF blocker (eg, certolizumab, etanercept, infliximab)

Some MEDICINES MAY INTERACT with adalimumab starter pack 40 MG/0.8 ML Pen (6 count). Tell your health care provider if you are taking any other medicines, especially any of the following:

• Abatacept, anakinra, corticosteroids (eg, prednisone), methotrexate, rituximab, tocilizumab, another TNF blocker (eg, certolizumab, etanercept, infliximab), or other medicines that may weaken the immune system (eg, 6-mercaptopurine, azathioprine) because the risk of serious infection may be increased. Check with your doctor or pharmacist if you are unsure if any of your medicines may weaken the immune system
• Cyclosporine, theophylline, or warfarin because their effectiveness may be decreased by adalimumab starter pack 40 MG/0.8 ML Pen (6 count)

This may not be a complete list of all interactions that may occur. Ask your health care provider if adalimumab starter pack 40 MG/0.8 ML Pen (6 count) may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

Can Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Adalimumab starter pack 40 MG/0.8 ML Pen (6 count) be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on Adalimumab starter pack 40 MG/0.8 ML Pen (6 count), the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Adalimumab starter pack 40 MG/0.8 ML Pen (6 count). We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 18 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology